ArticleJournal of nanobiotechnology2026
Gold nanocluster-complexed dressings for instant closure of bacteria-infected wound.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Rapid closure is crucial for effective wound healing. However, current wound dressings often fall short in this aspect. Herein, we present a light-responsive wound dressing (A@MC) composed of a heat-curable methyl cellulose (MC) hydrogel and aminophenylboronic acid (ABA)-modified gold nanoclusters (AGNCs). The A@MC is injectable and can conform, connect, and adhere to wounds of irregular shapes before gelation. Upon near-infrared (NIR) light irradiation, the photothermal effect of the AGNCs triggers an instant gelation and contraction of the dressing and simultaneously a sharp shrinkage of the wound. It achieves a shrinkage rate up to 46% within 5 min for bacteria-infected wound in mice. Moreover, the contraction of A@MC can achieve a rapid release (16%, 5 min) of the AGNCs, which can bind to bacteria through ABA-lipopolysaccharide (LPS) interaction, displaying a targeted antibacterial therapy. The A@MC realizes an accelerated healing (complete healing within 14 days) of multidrug-resistant Pseudomonas aeruginosa (P.a)-infected wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.